XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2023
Jul. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 13,197 $ 21,498
Available-for-sale securities 58,894 57,714
Interest receivable 420 387
Accounts receivable, net of allowance for doubtful accounts of $245 and $245 at October 31, 2023 and July 31, 2023, respectively 231 213
Prepaid expenses and other current assets 2,866 914
Investment in equity securities 294
Total current assets 77,466 82,941
Property and equipment, net 1,671 1,695
In-process research and development and patents 1,575 1,575
Other assets 42 9
TOTAL ASSETS 95,502 98,829
CURRENT LIABILITIES    
Accounts payable 471 333
Accrued expenses 325 763
Other current liabilities 115 1,023
Due to related parties 23 26
Total current liabilities 934 2,145
Other liabilities 56 55
TOTAL LIABILITIES 990 2,200
COMMITMENTS AND CONTINGENCIES
EQUITY    
Additional paid-in capital 265,487 264,010
Accumulated deficit (170,971) (167,333)
Treasury stock, at cost; 50,700 and 0 Class B shares as of October 31, 2023 and July 31, 2023 (79)
Accumulated other comprehensive loss related to unrealized loss on available-for-sale securities (146) (353)
Accumulated other comprehensive income related to foreign currency translation adjustment 3,668 3,725
Total equity 98,205 100,293
Noncontrolling interests (3,693) (3,664)
TOTAL EQUITY ATTRIBUTABLE TO RAFAEL HOLDINGS, INC. 94,512 96,629
TOTAL LIABILITIES AND EQUITY 95,502 98,829
Class A Common Stock    
EQUITY    
Common stock value 8 8
Class B Common Stock    
EQUITY    
Common stock value 238 236
Other Pharmaceuticals    
CURRENT ASSETS    
Investments 65
Hedge Funds    
CURRENT ASSETS    
Investments 2,318 4,984
Day Three Labs Inc    
CURRENT ASSETS    
Investments 2,581 2,797
Cyclo Therapeutics Inc    
CURRENT ASSETS    
Investments 9,849 4,763
Related Party    
CURRENT ASSETS    
Convertible note receivable, related party $ 1,858 $ 1,921